Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults wit…
Biotechnology
US, Philadelphia [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer Group
Configuration
| Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology Average | - - | - - | - - | 13,592.06 | 881.23 | 217.72 | -57.52 | 40.22 | 0.00 | 20.0932 | -0.38 | -1.1235 | -23.6211 | -0.09 | -0.08 | 7.4699 | - - | ||
| Maximum | - - | - - | - - | 458,604.00 | 65,349.00 | 25,407.00 | 99,050.00 | 5,305.00 | 0.01 | 1,336.3467 | 6.70 | 3.0051 | 85.3485 | 0.38 | 8.35 | 61.5621 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 0.00 | -1,175.00 | -56,335.00 | -1,185.00 | 0.00 | -164.8536 | -8.99 | -101.7758 | -1,444.7800 | -1.56 | -12.64 | 0.0007 | - - | ||
| Revolution Medicines, Inc. RVMD | 55.13 | -2.24 -3.90% | 1,944 vs. 1,156 | 9,273.00 | 0.00 | -116.00 | -163.00 | -1,253.00 | -0.7000 | -11.2467 | 0.0000 | 0.0000 | 0.0000 | -0.0672 | -0.0608 | 18.1763 | 168.00 | ||
| Karuna Therapeutics, Inc. KRTX | 329.83 | 0.09 0.03% | 1,283 vs. 971 | 12,599.00 | 0.00 | -113.00 | -111.00 | -997.00 | -3.0100 | -26.2644 | 0.0000 | 0.0000 | 0.0000 | -0.0908 | -0.0852 | 18.6075 | 38.00 | ||
| Denali Therapeutics Inc. DNLI | 25.05 | -3.40 -11.95% | 1,103 vs. 845 | 3,605.00 | 0.00 | -101.00 | -115.00 | -1,218.00 | -0.6800 | -7.5434 | 0.0000 | 0.0000 | 0.0000 | -0.0699 | -0.0644 | 11.3677 | 143.00 | ||
| Blueprint Medicines Corporation BPMC | 88.69 | -6.96 -7.28% | 982 vs. 601 | 5,634.00 | 96.00 | 89.00 | -102.00 | -2,250.00 | 1.4500 | 16.6530 | 0.0000 | 0.9168 | 0.9274 | 0.2869 | 0.0858 | 3.4266 | 63.00 | ||
| Cytokinetics, Incorporated CYTK | 50.22 | -4.48 -8.19% | 2,342 vs. 1,170 | 5,926.00 | 0.00 | -135.00 | -127.00 | -2,247.00 | -1.3300 | -13.7171 | 0.0000 | -1.7916 | -162.4467 | 0.3424 | -0.1679 | 6.9796 | 118.00 | ||
| Incyte Corporation INCY | 75.87 | -1.86 -2.39% | 3,464 vs. 1,874 | 14,616.00 | 880.00 | 169.00 | 209.00 | 329.00 | 0.7600 | 18.7480 | 0.0000 | 0.9308 | 0.1925 | 0.0314 | 0.0238 | 3.2913 | 192.00 | ||
| BioMarin Pharmaceutical Inc. BMRN | 63.42 | -2.18 -3.32% | 1,687 vs. 1,767 | 12,086.00 | 648.00 | 88.00 | 12.00 | -532.00 | 0.4700 | 46.3847 | 0.0000 | 0.7850 | 0.1366 | 0.0175 | 0.0129 | 1.5477 | 190.00 | ||
| Ultragenyx Pharmaceutical Inc. RARE | 44.75 | -2.89 -6.07% | 806 vs. 717 | 4,132.00 | 108.00 | -170.00 | -203.00 | -3,558.00 | -2.0300 | -5.7986 | 0.0000 | 0.7576 | -1.5683 | -1.2169 | -0.1306 | 2.1127 | 92.00 | ||
| Amicus Therapeutics, Inc. FOLD | 9.68 | -0.41 -4.06% | 2,649 vs. 2,392 | 2,892.00 | 110.00 | -48.00 | -31.00 | -2,732.00 | -0.1600 | -18.3766 | 0.0000 | 0.8576 | -0.4386 | -0.3705 | -0.0671 | 2.2240 | 298.00 | ||
| DICE Therapeutics, Inc. DICE | 47.55 | 0.03 0.06% | 4,332 vs. 1,753 | 2,270.00 | 0.00 | -34.00 | -30.00 | -248.00 | -0.7400 | -15.7831 | 0.0000 | 0.0000 | 0.0000 | -0.0671 | -0.0632 | 25.6858 | 47.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.